【レポートの概要（一部）】
Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Cystic Fibrosis Therapeutics Market Variables, Trends & Scope
3.1. Market Segmentation
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Key Opportunities Prioritized
3.4. Industry Analysis – Porter’s
3.5. Cystic Fibrosis Therapeutics Market-SWOT Analysis, By Factor (Political & Legal, Economic and Technological), 2015
Chapter 4. Cystic Fibrosis Therapeutics Market: Drug Class Estimates & Trend Analysis
4.1. Cystic Fibrosis Therapeutics Market Share by Drug Class, 2016 & 2025 (USD Million)
4.2. Pancreatic Enzyme Supplements
4.2.1. Market estimates and forecast, 2014 – 2025 (USD Million)
4.3. Mucolytics
4.3.1. Market estimates and forecast, 2014 – 2025 (USD Million)
4.4. Bronchodilators
4.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
4.5. CFTR Modulators
4.5.1. Market estimates and forecast, 2014 – 2025 (USD Million)
Chapter 5. Cystic Fibrosis Therapeutics Market: Route of Administration Estimates & Trend Analysis
5.1. Cystic Fibrosis Therapeutics Market Share by Route of Administration, 2016 & 2025 (USD Million)
5.2. Oral Drugs
5.2.1. Market estimates and forecast, 2014 – 2025 (USD Million)
5.3. Inhaled Drugs
5.3.1. Market estimates and forecast, 2014 – 2025 (USD Million)
Chapter 6. Cystic Fibrosis Therapeutics Market: Regional Outlook, by Drug Class and Route of Administration
6.1. Cystic Fibrosis Therapeutics Market Shares by Region, 2016 & 2025 (USD Million)
6.2. North America
6.2.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.2.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.2.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.2.4. U.S.
6.2.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.2.4.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.2.4.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.2.5. Canada
6.2.5.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.2.5.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.2.5.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.3. Europe
6.3.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.3.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.3.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.3.4. Germany
6.3.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.3.4.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.3.4.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.3.5. UK
6.3.5.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.3.5.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.3.5.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.4. Asia Pacific
6.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.4.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.4.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.4.4. China
6.4.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.4.4.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.4.4.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.4.5. Japan
6.4.5.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.4.5.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.4.5.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.5. Latin America
6.5.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.5.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.5.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.5.4. Brazil
6.5.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.5.4.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.5.4.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.5.5. Mexico
6.5.5.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.5.5.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.5.5.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.6. Middle East & Africa
6.6.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.6.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.6.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
6.6.4. South Africa
6.6.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
6.6.4.2. Market estimates and forecast by drug class, 2014 – 2025 (USD Million)
6.6.4.3. Market estimates and forecast by route of administration, 2014 – 2025 (USD Million)
Chapter 7. Competitive Landscape
7.1. Strategic Framework
7.2. Company Profiles
7.2.1. AbbVie Inc.
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. F. Hoffmann-La Roche Ltd
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Gilead
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Novartis AG
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Vertex Pharmaceuticals Incorporated
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. AIT (Advanced Inhalation Therapies)
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Alaxia
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Teva Pharmaceutical Industries Ltd.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Merck & Co. Inc.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Alcresta Therapeutics, Inc.
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. ALLERGAN
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. AstraZeneca
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
【レポート販売概要】
■ タイトル：嚢胞性線維症（CF）治療の世界市場分析■ 英文：Cystic Fibrosis (CF) Therapeutics Market Analysis By Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, CFTR Modulators), By Route of Administration, By Region, And Segment Forecasts, 2014 - 2025
■ 発行日：2017年6月2日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW70714001
■ 調査対象地域：グローバル
- UAV用ソフトウェアの世界市場• Do you need UAV Software market data?• Succinct UAV Software market analysis? • Technological insight? • Clear competitor analysis? • Actionable business recommendations? Read on to discover how this definitive report can transform your own research and save you time. The global UAV Software market consists of worldwide government spending on the procurement, development, and upgrades of UAV sof …
- 民間航空機・軍用航空機MROの世界市場ABSTRACTAbout Commercial and Military Aircraft MRO Maintenance, repair, and overhaul (MRO) enhances the life of an aircraft by increasing its operational efficiency. It includes services such as routine check-up, inspection, repair, and modification of aircraft and its components, assuring the safety and airworthiness of an aircraft. MRO is performed for airframes, engines, and components and incl …
- 世界のコネクテッドカー市場：LTE及びテレマティクスアプリケーションConnected vehicles represent one of the most important innovation areas for LTE technology, which also adds a new dimension for the transportation systems. Connected vehicle refers to the use of IoT and LTE technology in the car with the use of smartphones or other technologies typically manifest as handheld or wearable devices. The basic solutions involve: Navigation, Telematics and Infotainment. …
- 外側上顆炎治療の世界市場2019-2023About this market Lateral epicondylitis is common in people who participate in physical activities such as racket sports, hockey, canoeing, weight-lifting, wrestling, rowing, and swimming. Moreover, it can also occur in people who apply more pressure on extensor carpi radialis brevis and longus muscles of the forearm, as a part of their work. These people observe severe and long-term pain around t …
- クラウド型マイクログリッドサービス（MaaS）の世界市場予測2022The microgrid as a service (MaaS) market was valued at USD 774.9 Million in 2015 and is expected to reach USD 2,241.6 Million by 2022, at a CAGR of 15.86% during the forecast period. Reduction in operational costs and negligible upfront investments by MaaS end users, rising demand from MaaS from hospitals, universities, and remote regions, and high investments by governments in microgrid infrastru …
- ICT調達動向：金融産業部門 – 企業のICT投資計画Why was the report written? To highlight the criteria on which financial market institutions select their IT providers as well as the roles which have influence while making IT purchasing decisions. What is the current market landscape and what is changing? Financial market institutions are keen to deploy their technologies on-site as they have to adhere to strict compliance regulations relating t …
- 頭蓋内圧亢進治療のグローバル臨床試験動向（2014年H2）Intracranial Hypertension Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Intracranial Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Intracranial Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intracranial Hypertension. It includes an overview of the trial …
- 世界の薬物複合体市場：市場機会分析Ever since the first attempt in the 1980s to use antibody based drugs as therapeutic agents, the application and use of monoclonal antibody-drug conjugates has evolved in several ways. The major advantage of using Antibody Drug Conjugates (ADC) is that it brings together the best characteristics of both antibodies and the cytotoxic potential of chemotherapy. This offers significant opportunity for …
- 高純度アルミナの世界市場：タイプ別（4N高純度アルミナ、5N高純度アルミナ、6N高純度アルミナ）、技術別（加水分解および塩酸浸出）、用途別（LED電球、半導体基板、リチウムイオン電池、光学レンズ、バイオ医療機器、 その他）The global high purity alumina market was valued at $1.1 billion in 2018, and is projected to reach $5.1 billion by 2026, growing at a CAGR of 21.7% from 2019 to 2026. High-purity alumina (HPA) is a premium product that falls under non-metallurgical alumina products, characterized by a minimum purity level of 99.99%. HPA is utilized as a base material to manufacture sapphire substrates in applicat …
- 超小型LEDの世界市場予測（～2025年）：LEDディスプレイパネル、LED照明機器The micro-LED market is estimated to be USD 254.1 Million in 2017 and is likely to reach USD 19,921.3 Million by 2025, at CAGR of 54.7% between 2019 and 2025. Increasing demand for brighter and more power efficient display panels for several applications is the main driver of the market. The market is also driven by factors such as increase in applications, high adoption rate of near-to-eye (NTE) …
- ニコチンガムの世界市場2019-2023About this market Increase in number of people quitting smoking to drive market growth. It is estimated that tobacco will cause more than 8 million deaths annually by 2030. In the US, cigarette smoking is responsible for nearly 480,000 deaths every year. The number of quit attempts it takes before smokers are successful at quitting smoking varies. According to the American Cancer Society, it takes …
- 世界のスマート鉄道システム市場：製品別、地域別Global Smart Railway Systems Market: About this market Technavio’s smart railway systems market analysis considers sales from solutions, components, and services. Our study also finds the sales of smart railway systems in APAC, Europe, MEA, North America, and South America. In 2019, the solutions segment had a significant market share, and this trend is expected to continue over the forecast perio …
- 抗菌ガラスの世界市場分析：有効成分別（銀、その他）、用途別（病院、食品･飲料、軍事施設、家庭用）、分析とセグメント予測 -2020The global antibacterial glass market is expected to reach USD 222 million by 2020, according to a new study by Grand View Research, Inc. Need to prevent the growing number of nosocomial or Hospital Acquired Infections (HAI) is expected to be the key driving force for the market over the forecast period. Antibacterial glass offers an architectural solution for the prevention of infections, which i …
- 自動車用潤滑油の世界市場：エンジンオイル、ブレーキオイル、トランスミッションフルード、ギアオイルAbout Automotive Lubricants Lubricants are materials used to reduce friction between two surfaces of equipment or components. They are usually in oil, semi-fluid, or solid state. Automotive lubricants include fluids such as engine oil, transmission fluid, gear oil, and brake oil. These are used to reduce the friction between the surfaces in contact, consequently improving the efficiency of the aut …
- スマートコーヒーメーカーの世界市場2017-2021About Smart Coffee MakerA coffee maker is a countertop appliance that brews hot coffee. Smart coffee makers are the part of automatic coffee brewing machines. Smart coffee makers are enabled with Wi-Fi and Bluetooth and can be operated by using an app on a smartphone. These smart coffee makers can be used from distant locations and offer the benefit of remotely controlling the device through smart …
